SCREENIVF验证研究:一种在生育治疗开始前筛查女性或男性情绪适应不良风险的工具
在荷兰大学医院接受IVF/ICSI治疗的468名女性和383名男性中验证SCREENIVF的结构效度和效标效度。因子模型拟合良好,女性HADS子量表敏感性61%-98%、特异性53%-65%、阳性预测值13%-56%、阴性预测值70%-99%,男性分别为38%-100%、71%-75%、9%-27%、92%-100%。SCREENIVF结构效度良好,同期效度优于预测效度,应在治疗开始时使用,不应作为预测工具。
要点
- SCREENIVF因子模型在女性和男性中均显示良好拟合。
- 女性HADS子量表敏感性61%-98%,特异性53%-65%。
- 男性敏感性38%-100%,特异性71%-75%;同期效度优于预测效度。
核心结论
- SCREENIVF结构效度良好,但同期效度优于预测效度。
- SCREENIVF最有效的使用时机是生育诊所治疗开始时,不应作为预测工具使用。
研究设计与样本
- 前瞻性纵向研究,嵌套于一项随机对照试验中。
- 在大学医院生育诊所接受IVF/卵胞浆内单精子注射(ICSI)治疗的夫妇,包括468名女性和383名男性,完成SCREENIVF。
主要发现
- 女性和男性的比较拟合指数与近似误差均方根显示因子模型拟合良好。
- 女性HADS子量表敏感性范围为61%-98%,特异性53%-65%,阳性预测值13%-56%,阴性预测值70%-99%。
- 男性敏感性范围为38%-100%,特异性71%-75%,阳性预测值9%-27%,阴性预测值92%-100%。
- 女性HADS方差被SCREENIVF总分量表预测变量解释的比例:时间1为68.7%,时间2为42.5%,时间3为38.9%。
- 男性HADS方差被SCREENIVF总分量表预测变量解释的比例:时间1为58.1%,时间2为46.5%,时间3为37.3%。
临床怎么用
- SCREENIVF最有效的使用时机是生育诊所治疗开始时,不应作为预测工具使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine construct and criterion validity of the Dutch SCREENIVF among women and men undergoing a fertility treatment. DESIGN: A prospective longitudinal study nested in a randomized controlled trial. SETTING: University hospital. PATIENT(S): Couples, 468 women and 383 men, undergoing an IVF/intracytoplasmic sperm injection (ICSI) treatment in a fertility clinic, completed the SCREENIVF. MAIN OUTCOME MEASURE(S): Construct and criteria validity of the SCREENIVF. RESULT(S): The comparative fit index and root mean square error of approximation for women and men show a good fit of the factor model. Across time, the sensitivity for Hospital Anxiety and Depression Scale subscale in women ranged from 61%-98%, specificity 53%-65%, predictive value of a positive test (PVP) 13%-56%, predictive value of a negative test (PVN) 70%-99%. The sensitivity scores for men ranged from 38%-100%, specificity 71%-75%, PVP 9%-27%, PVN 92%-100%. A prediction model revealed that for women 68.7% of the variance in the Hospital Anxiety and Depression Scale on time 1 and 42.5% at time 2 and 38.9% at time 3 was explained by the predictors, the sum score scales of the SCREENIVF. For men, 58.1% of the variance in the Hospital Anxiety and Depression Scale on time 1 and 46.5% at time 2 and 37.3% at time 3 was explained by the predictors, the sum score scales of the SCREENIVF. CONCLUSION(S): The SCREENIVF has good construct validity but the concurrent validity is better than the predictive validity. SCREENIVF will be most effectively used in fertility clinics at the start of treatment and should not be used as a predictive tool.
引用
- Ockhuijsen HDL, van Smeden M, van den Hoogen A, et al. Validation study of the SCREENIVF: an instrument to screen women or men on risk for emotional maladjustment before the start of a fertility treatment. Fertil Steril. 2017. PMID: 28501369. doi:10.1016/j.fertnstert.2017.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。